Antitumor activity of MDV3100 in pre- and post-docetaxel advanced prostate cancer: Long-term follow-up of a phase I/II study Meeting Abstract


Authors: Higano, C. S.; Beer, T. M.; Taplin, M.; Efstathiou, E.; Anand, A.; Hirmand, M.; Fleisher, M.; Scher, H. I.; for the Prostate Cancer Clinical Trials Consortium
Abstract Title: Antitumor activity of MDV3100 in pre- and post-docetaxel advanced prostate cancer: Long-term follow-up of a phase I/II study
Meeting Title: 2011 Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 29
Issue: 7 Suppl.
Meeting Dates: 2011 Feb 17-19
Meeting Location: Orlando, FL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2011-03-01
Language: English
ACCESSION: WOS:000208880700135
DOI: 10.1200/jco.2011.29.7_suppl.134
PROVIDER: wos
Notes: Meeting Abstract: 134 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Martin Fleisher
    312 Fleisher
  2. Howard Scher
    1130 Scher
  3. Aseem Anand
    61 Anand